{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:22:52Z","timestamp":1778750572658,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004515","name":"Universiti Kebangsaan Malaysia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004515","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12602-025-10747-4","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T03:12:48Z","timestamp":1757646768000},"page":"4222-4232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transcriptomic and Molecular Insights into the Response of Multidrug-Resistant Helicobacter pylori to Human Neutrophil Peptide 1 (HNP-1)"],"prefix":"10.1007","volume":"18","author":[{"given":"Zarith Nameyrra","family":"Md Nesran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfizah","family":"Hanafiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asif","family":"Sukri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur Azlina","family":"Mohd Fahami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja Affendi","family":"Raja Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno Silvester","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"key":"10747_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13182944","author":"V Jearth","year":"2023","unstructured":"Jearth V, Rath MM, Chatterjee A, Kale A, Panigrahi MK (2023) Drug-resistant Helicobacter pylori: diagnosis and evidence-based approach. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics13182944","journal-title":"Diagnostics"},{"issue":"6269","key":"10747_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1126\/science.aad2545","volume":"351","author":"F Maixner","year":"2016","unstructured":"Maixner F, Krause-Kyora B, Turaev D et al (2016) The 5300-year-old Helicobacter pylori genome of the Iceman. Science 351(6269):162\u2013165. https:\/\/doi.org\/10.1126\/science.aad2545","journal-title":"Science"},{"issue":"2","key":"10747_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1053\/j.gastro.2021.04.012","volume":"161","author":"T Rokkas","year":"2021","unstructured":"Rokkas T, Gisbert JP, Malfertheiner P et al (2021) Comparative effectiveness of multiple different first-line treatment regimens for Helicobacter pylori infection: a network meta-analysis. Gastroenterology 161(2):495-507.e2. https:\/\/doi.org\/10.1053\/j.gastro.2021.04.012","journal-title":"Gastroenterology"},{"issue":"9","key":"10747_CR4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41575-021-00449-x","volume":"18","author":"E Tshibangu-Kabamba","year":"2021","unstructured":"Tshibangu-Kabamba E, Yamaoka Y (2021) Helicobacter pylori infection and antibiotic resistance \u2014 from biology to clinical implications. Nat Rev Gastroenterol Hepatol 18(9):613\u2013629. https:\/\/doi.org\/10.1038\/s41575-021-00449-x","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10747_CR5","doi-asserted-by":"publisher","first-page":"1128497","DOI":"10.3389\/fmicb.2023.1128497","volume":"14","author":"RI Dasc\u0103lu","year":"2023","unstructured":"Dasc\u0103lu RI, Bolocan A, P\u0103duaru DN et al (2023) Multidrug resistance in Helicobacter pylori infection. Front Microbiol 14:1128497. https:\/\/doi.org\/10.3389\/fmicb.2023.1128497","journal-title":"Front Microbiol"},{"issue":"9","key":"10747_CR6","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3390\/antibiotics10091095","volume":"10","author":"M Rima","year":"2021","unstructured":"Rima M, Rima M, Fajloun Z, Sabatier JM, Bechinger B, Naas T (2021) Antimicrobial peptides: a potent alternative to antibiotics. Antibiotics 10(9):1095. https:\/\/doi.org\/10.3390\/antibiotics10091095","journal-title":"Antibiotics"},{"key":"10747_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/675391","volume":"2013","author":"M Pushpanathan","year":"2013","unstructured":"Pushpanathan M, Gunasekaran P, Rajendhran J (2013) Antimicrobial peptides: versatile biological properties. Int J Pept 2013:675391. https:\/\/doi.org\/10.1155\/2013\/675391","journal-title":"Int J Pept"},{"key":"10747_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.582779","volume":"11","author":"Y Huan","year":"2020","unstructured":"Huan Y, Kong Q, Mou H, Yi H (2020) Antimicrobial peptides: classification, design, application and research progress in multiple fields. Front Microbiol 11:582779. https:\/\/doi.org\/10.3389\/fmicb.2020.582779","journal-title":"Front Microbiol"},{"issue":"13","key":"10747_CR9","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.3390\/molecules25133048","volume":"25","author":"M Drayton","year":"2020","unstructured":"Drayton M, Kizhakkedath JN, Strau SK (2020) Towards robust delivery of antimicrobial peptides to combat bacterial resistance. Molecules 25(13):3048. https:\/\/doi.org\/10.3390\/molecules25133048","journal-title":"Molecules"},{"issue":"23","key":"10747_CR10","doi-asserted-by":"publisher","first-page":"9891","DOI":"10.1007\/s00253-020-10945-w","volume":"104","author":"P Roszczenko-Jasi\u0144ska","year":"2020","unstructured":"Roszczenko-Jasi\u0144ska P, Wojty\u015b MI, Jagusztyn-Krynicka EK (2020) Helicobacter pylori treatment in the post-antibiotics era\u2014searching for new drug targets. Appl Microbiol Biotechnol 104(23):9891\u20139905. https:\/\/doi.org\/10.1007\/s00253-020-10945-w","journal-title":"Appl Microbiol Biotechnol"},{"key":"10747_CR11","doi-asserted-by":"publisher","unstructured":"Sukri A, Lopes BS, Hanafiah A (2021)\u00a0The emergence\u00a0of multidrug-resistant Helicobacter pylori in Southeast Asia: a systematic review on the trends and intervention strategies using antimicrobial peptides. Antibiotics 10(9):1061. https:\/\/doi.org\/10.3390\/antibiotics10091061","DOI":"10.3390\/antibiotics10091061"},{"issue":"1","key":"10747_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12555","volume":"24","author":"A Neshani","year":"2019","unstructured":"Neshani A, Zare H, Akbari Eidgahi MR, Hooshyar Chichaklu A, Movaqar A, Ghazvini K (2019) Review of antimicrobial peptides with anti-Helicobacter pylori activity. Helicobacter 24(1):e12555. https:\/\/doi.org\/10.1111\/hel.12555","journal-title":"Helicobacter"},{"issue":"10","key":"10747_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002491","volume":"7","author":"S Dabirian","year":"2013","unstructured":"Dabirian S, Taslimi Y, Zahedifard F et al (2013) Human neutrophil peptide-1 (HNP-1): a new anti-leishmanial drug candidate. PLoS Negl Trop Dis 7(10):e2491. https:\/\/doi.org\/10.1371\/journal.pntd.0002491","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10747_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1034\/j.1399-3011.2003.00068.x","volume":"62","author":"Z Wu","year":"2003","unstructured":"Wu Z, Prahl A, Powell R, Ericksen B, Lubkowski J, Lu W (2003) From pro defensins to defensins: synthesis and characterization of human neutrophil pro \u03b1-defensin-1 and its mature domain. J Pept Res 62(2):53\u201362. https:\/\/doi.org\/10.1034\/j.1399-3011.2003.00068.x","journal-title":"J Pept Res"},{"issue":"9","key":"10747_CR15","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nri1180","volume":"3","author":"T Ganz","year":"2003","unstructured":"Ganz T (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3(9):710\u2013720. https:\/\/doi.org\/10.1038\/nri1180","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10747_CR16","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.febslet.2010.03.004","volume":"584","author":"E de Leeuw","year":"2010","unstructured":"de Leeuw E, Li C, Zeng P et al (2010) Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II. FEBS Lett 584(8):1543\u20131548. https:\/\/doi.org\/10.1016\/j.febslet.2010.03.004","journal-title":"FEBS Lett"},{"issue":"3","key":"10747_CR17","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1080\/07391102.2020.1823249","volume":"40","author":"N Moazzezy","year":"2022","unstructured":"Moazzezy N, Rismani E, Rezaei M et al (2022) Computational evaluation of modified peptides from human neutrophil peptide 1 (HNP-1). J Biomol Struct Dyn 40(3):1163\u20131171. https:\/\/doi.org\/10.1080\/07391102.2020.1823249","journal-title":"J Biomol Struct Dyn"},{"issue":"11","key":"10747_CR18","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.1007\/s00253-018-8982-9","volume":"102","author":"X Zhang","year":"2018","unstructured":"Zhang X, Jiang A, Qi B et al (2018) Secretion expression of human neutrophil peptide 1 (HNP1) in Pichia pastoris and its functional analysis against antibiotic-resistant Helicobacter pylori. Appl Microbiol Biotechnol 102(11):4817\u20134827. https:\/\/doi.org\/10.1007\/s00253-018-8982-9","journal-title":"Appl Microbiol Biotechnol"},{"issue":"Supplement_5","key":"10747_CR19","doi-asserted-by":"publisher","first-page":"S486","DOI":"10.1093\/infdis\/jiac389","volume":"226","author":"X Tang","year":"2022","unstructured":"Tang X, Shen Y, Song X et al (2022) Reassessment of the broth microdilution method for susceptibility testing of Helicobacter pylori. J Infect Dis 226(Supplement_5):S486\u2013S492. https:\/\/doi.org\/10.1093\/infdis\/jiac389","journal-title":"J Infect Dis"},{"issue":"12","key":"10747_CR20","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15(12):550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8","journal-title":"Genome Biol"},{"key":"10747_CR21","unstructured":"R Core Team (2020) R: A language and environment for statistical computing. Published online"},{"issue":"1","key":"10747_CR22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s10989-020-10127-2","volume":"27","author":"BS Fazly Bazzaz","year":"2021","unstructured":"Fazly Bazzaz BS, Seyedi S, Hoseini Goki N, Khameneh B (2021) Human antimicrobial peptides: spectrum, mode of action and resistance mechanisms. Int J Pept Res Ther 27(1):801\u2013816. https:\/\/doi.org\/10.1007\/s10989-020-10127-2","journal-title":"Int J Pept Res Ther"},{"issue":"8","key":"10747_CR23","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1089\/sur.2018.194","volume":"19","author":"DE Fry","year":"2018","unstructured":"Fry DE (2018) Antimicrobial peptides. Surg Infect (Larchmt) 19(8):804\u2013811. https:\/\/doi.org\/10.1089\/sur.2018.194","journal-title":"Surg Infect (Larchmt)"},{"key":"10747_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.616979","volume":"12","author":"GS Dijksteel","year":"2021","unstructured":"Dijksteel GS, Ulrich MMW, Middelkoop E, Boekema BKHL (2021) Review: lessons learned from clinical trials using antimicrobial peptides (AMPs). Front Microbiol 12:616979. https:\/\/doi.org\/10.3389\/fmicb.2021.616979","journal-title":"Front Microbiol"},{"issue":"1","key":"10747_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/fcp.12499","volume":"34","author":"A Bolatchiev","year":"2020","unstructured":"Bolatchiev A, Baturin V, Bazikov I, Maltsev A, Kunitsina E (2020) Effect of antimicrobial peptides HNP-1 and hBD-1 on Staphylococcus aureus strains in vitro and in vivo. Fundam Clin Pharmacol 34(1):102\u2013108. https:\/\/doi.org\/10.1111\/fcp.12499","journal-title":"Fundam Clin Pharmacol"},{"issue":"26","key":"10747_CR26","doi-asserted-by":"publisher","first-page":"9124","DOI":"10.1039\/D1SC01133B","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Liu Y, Tang Y et al (2021) Antimicrobial \u03b1-defensins as multi-target inhibitors against amyloid formation and microbial infection. Chem Sci 12(26):9124\u20139139. https:\/\/doi.org\/10.1039\/D1SC01133B","journal-title":"Chem Sci"},{"key":"10747_CR27","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.10455","volume":"8","author":"A Bolatchiev","year":"2020","unstructured":"Bolatchiev A (2020) Antibacterial activity of human defensins against Staphylococcus aureus and Escherichia coli. PeerJ 8:e10455. https:\/\/doi.org\/10.7717\/peerj.10455","journal-title":"PeerJ"},{"issue":"4","key":"10747_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1469-0691.2011.03581.x","volume":"18","author":"X Vila-Farres","year":"2012","unstructured":"Vila-Farres X, Garcia de la Maria C, L\u00f3pez-Rojas R, Pach\u00f3n J, Giralt E, Vila J (2012) In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii. Clin Microb Infect 18(4):383\u2013387. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03581.x","journal-title":"Clin Microb Infect"},{"issue":"4","key":"10747_CR29","doi-asserted-by":"publisher","first-page":"e0035824","DOI":"10.1128\/spectrum.00358-24","volume":"12","author":"M Escobar-Salom","year":"2024","unstructured":"Escobar-Salom M, Barcel\u00f3 IM, Rojo-Molinero E et al (2024) In vitro activity of human defensins HNP-1 and hBD-3 against multidrug-resistant ESKAPE Gram-negatives of clinical origin and selected peptidoglycan recycling-defective mutants. Microbiol Spectr 12(4):e0035824. https:\/\/doi.org\/10.1128\/spectrum.00358-24","journal-title":"Microbiol Spectr"},{"issue":"11","key":"10747_CR30","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.cmi.2016.07.013","volume":"22","author":"F M\u00e9graud","year":"2016","unstructured":"M\u00e9graud F, Lehours P, Vale FF (2016) The history of Helicobacter pylori\u202f: from phylogeography to paleomicrobiology. Clin Microbiol Infect 22(11):922\u2013927. https:\/\/doi.org\/10.1016\/j.cmi.2016.07.013","journal-title":"Clin Microbiol Infect"},{"key":"10747_CR31","doi-asserted-by":"crossref","unstructured":"Cavalli-Sforza L, Menozzi P, Piazza A (1996)\u00a0The history and geography of human genes. Princeton University Press","DOI":"10.1515\/9780691187266"},{"issue":"4","key":"10747_CR32","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.tim.2023.09.009","volume":"32","author":"D Balint","year":"2024","unstructured":"Balint D, Brito IL (2024) Human\u2013gut bacterial protein\u2013protein interactions: understudied but impactful to human health. Trends Microbiol 32(4):325\u2013332. https:\/\/doi.org\/10.1016\/j.tim.2023.09.009","journal-title":"Trends Microbiol"},{"key":"10747_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2022.958480","volume":"3","author":"KF Johnstone","year":"2022","unstructured":"Johnstone KF, Herzberg MC (2022) Antimicrobial peptides: defending the mucosal epithelial barrier. Front Oral Health 3:958480. https:\/\/doi.org\/10.3389\/froh.2022.958480","journal-title":"Front Oral Health"},{"issue":"2","key":"10747_CR34","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/157340911795677602","volume":"7","author":"XY Meng","year":"2011","unstructured":"Meng XY, Zhang HX, Mezei M, Cui M (2011) Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des 7(2):146\u2013157. https:\/\/doi.org\/10.2174\/157340911795677602","journal-title":"Curr Comput Aided Drug Des"},{"issue":"2","key":"10747_CR35","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.str.2009.11.012","volume":"18","author":"N London","year":"2010","unstructured":"London N, Movshovitz-Attias D, Schueler-Furman O (2010) The structural basis of peptide-protein binding strategies. Structure 18(2):188\u2013199. https:\/\/doi.org\/10.1016\/j.str.2009.11.012","journal-title":"Structure"},{"issue":"6802","key":"10747_CR36","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/35030019","volume":"407","author":"AP Carter","year":"2000","unstructured":"Carter AP, Clemons WM, Brodersen DE, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V (2000) Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature 407(6802):340\u2013348. https:\/\/doi.org\/10.1038\/35030019","journal-title":"Nature"},{"issue":"4","key":"10747_CR37","doi-asserted-by":"publisher","first-page":"528","DOI":"10.5009\/gnl20225","volume":"15","author":"SY Kim","year":"2021","unstructured":"Kim SY, Park JM, Lim CH et al (2021) Types of 23S ribosomal RNA point mutations and therapeutic outcomes for Helicobacter pylori. Gut Liver 15(4):528\u2013536. https:\/\/doi.org\/10.5009\/gnl20225","journal-title":"Gut Liver"},{"issue":"3","key":"10747_CR38","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1128\/MMBR.63.3.642-674.1999","volume":"63","author":"A Marais","year":"1999","unstructured":"Marais A, Mendz GL, Hazell SL, M\u00e9graud F (1999) Metabolism and genetics of Helicobacter pylori: the genome era. Microbiol Mol Biol Rev 63(3):642\u2013674. https:\/\/doi.org\/10.1128\/MMBR.63.3.642-674.1999","journal-title":"Microbiol Mol Biol Rev"},{"issue":"3","key":"10747_CR39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.plipres.2013.02.002","volume":"52","author":"JB Parsons","year":"2013","unstructured":"Parsons JB, Rock CO (2013) Bacterial lipids: metabolism and membrane homeostasis. Prog Lipid Res 52(3):249\u2013276. https:\/\/doi.org\/10.1016\/j.plipres.2013.02.002","journal-title":"Prog Lipid Res"},{"issue":"11","key":"10747_CR40","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1128\/AAC.00952-15","volume":"59","author":"MJ Choi","year":"2015","unstructured":"Choi MJ, Ko KS (2015) Loss of hypermucoviscosity and increased fitness cost in colistin-resistant Klebsiella pneumoniae sequence type 23 strains. Antimicrob Agents Chemother 59(11):6763\u20136773. https:\/\/doi.org\/10.1128\/AAC.00952-15","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10747_CR41","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/antibiotics6040028","volume":"6","author":"G Da Silva","year":"2017","unstructured":"Da Silva G, Domingues S (2017) Interplay between colistin resistance, virulence and fitness in Acinetobacter baumannii. Antibiotics 6(4):28. https:\/\/doi.org\/10.3390\/antibiotics6040028","journal-title":"Antibiotics"},{"issue":"7","key":"10747_CR42","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1128\/AAC.00121-14","volume":"58","author":"J Olivares","year":"2014","unstructured":"Olivares J, \u00c1lvarez-Ortega C, Martinez JL (2014) Metabolic compensation of fitness costs associated with overexpression of the multidrug ffflux pump MexEF-OprN in Pseudomonas aeruginosa. Antimicrob Agents Chemother 58(7):3904\u20133913. https:\/\/doi.org\/10.1128\/AAC.00121-14","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10747_CR43","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00500-17","volume":"8","author":"J Olivares Pacheco","year":"2017","unstructured":"Olivares Pacheco J, Alvarez-Ortega C, Alcalde Rico M, Mart\u00ednez JL (2017) Metabolic compensation of fitness costs is a general outcome for antibiotic-resistant Pseudomonas aeruginosa mutants overexpressing efflux pumps. MBio 8(4):e00500\u201317. https:\/\/doi.org\/10.1128\/mBio.00500-17","journal-title":"MBio"},{"issue":"9","key":"10747_CR44","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1074\/mcp.M600431-MCP200","volume":"6","author":"S Wagner","year":"2007","unstructured":"Wagner S, Baars L, Ytterberg AJ et al (2007) Consequences of membrane protein overexpression in Escherichia coli. Mol Cell Proteomics 6(9):1527\u20131550. https:\/\/doi.org\/10.1074\/mcp.M600431-MCP200","journal-title":"Mol Cell Proteomics"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10747-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-025-10747-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10747-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:01:06Z","timestamp":1778749266000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-025-10747-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10747"],"URL":"https:\/\/doi.org\/10.1007\/s12602-025-10747-4","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author reports no conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}